Becton, Dickinson and Company (BDX): A Bull Case Theory
We came across a bullish thesis on Becton, Dickinson and Company on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on BDX. Becton, Dickinson and Company's share was trading at $176.66 as of February 26th. BDX’s trailing and forward P/E were 35.03 and 12.82, respectively according to Yahoo Finance.
Becton, Dickinson and Company (BDX) remains a steady healthcare leader supported by durable, recurring demand across medical devices and diagnostics, positioning it as an attractive total return opportunity into 2026. The company operates through five segments—Medical Essentials, Connected Care, BioPharma Systems, Interventional, and Life Sciences—providing critical products such as IV catheters, medication delivery systems, pre-fillable drug solutions, and advanced patient monitoring platforms.
With a global footprint spanning the U.S., China, Germany, and other key markets, BDX serves hospitals, laboratories, researchers, and pharmaceutical companies, reinforcing its diversified and resilient revenue base.
Despite this stability, the stock appears discounted relative to historical dividend yield ranges. Based on its current $4.20 dividend, the historically repetitive high dividend (undervalued) yield of 1.6% implies a $255 share price, while shares recently traded near $192, reflecting a 2.1% yield and roughly a 33% discount to that undervalued threshold. On the other end, the historically repetitive low dividend (overvalue) yield of 1.1% suggests a theoretical valuation of $355 per share, representing as much as 90% upside from current levels.
Internally, fundamentals remain sound: ROIC stands at 10%, free cash flow yield at 4%, and P/EBV at 0.9. Economic EPS of $6.45 exceeds reported GAAP EPS of $5.81, and economic book value is $217.66 per share, above the current price. While analysts have highlighted near-term concerns, those risks appear embedded in the stock, whereas cash flow metrics and valuation signals point to mispricing. The recommended action is to buy BDX.
Previously, we covered a
Becton, Dickinson and Company is not on our list of the
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
JPMorgan Brings JPM Coin to Ethereum for Institutions
How Ethereum Could Stay Secure Even If Today’s Online Locks Stop Working
Cardano Price Prediction: Can ADA Defend $0.22 as Hoskinson Builds a New Programming Language?
VIPAI Asset Sell-Off and Selective Rotation in Crypto
1. Technology stocks fell sharply as investor interest shifted toward energy and selected defensive assets. From October 10 to 16, the Nasdaq 100 declined 5.49% and the S&P 500 fell 1.95%, while the Dow gained 0.67% and WTI crude rose 10.41%. BTC, ETH, and SOL declined 1.27%, 2.65%, and 4.44%, respectively. This week's technology earnings will be an important test of whether revenue growth, margins, and cash flow can justify current valuations. Better-than-expected results could help stabilize markets in the near term. 2. Crypto continues to see pockets of strong activity, but a broad-based altcoin season has yet to materialize. CoinMarketCap's (CMC) Altcoin Season Index stood at 54 as of the October 18 UTC daily observation, below the altcoin-season threshold of 75, while BTC dominance rose to 60.08%. Our proxy leverage ratio fluctuated between 4.00 and 4.07 during the week, showing no sustained increase and suggesting limited appetite for additional leverage. Meanwhile, as major exchanges expand access to traditional financial assets, the recent sell-off in AI-related equities could attract short-term speculative capital away from crypto. Such capital rotation could make it more difficult for a new altcoin season to take hold. 3. Papertrade's loss-to-mine model has generated significant interest across the crypto community. The protocol combines high-leverage derivatives trading with zero slippage and a mechanism that rewards trading losses with PAPER tokens. Across the eight complete UTC days from October 10 to 17, cumulative reported revenue reached approximately $56.08 million, including $51.90 million distributed to token holders. With growing participation from key opinion leaders (KOLs), Papertrade has reportedly ranked among the top three platforms by profitability in the broader market recently. Assets to watch: BTC, ETH, SOL, ARB, OP, SKHYNIX, SKHY, META, TSLA, LRCX, and SPCX. Key research priorities this week: Cash flow performance in technology earnings; the relative discount and holding costs of the two SK Hynix contracts; and U.S. initial jobless claims and PMI data. Weekly market data cover the period through October 16, while research information was verified through October 18. Observation periods are specified separately for each chart.
Crypto prices
More
